MicroRNA-144 affects radiotherapy sensitivity by promoting proliferation, migration and invasion of breast cancer cells.

@article{Yu2015MicroRNA144AR,
  title={MicroRNA-144 affects radiotherapy sensitivity by promoting proliferation, migration and invasion of breast cancer cells.},
  author={Lei Yu and Yanming Yang and Jiguang Hou and Chengwei Zhai and Yunhao Song and Zhiliang Zhang and Ling Qiu and Xiaojing Jia},
  journal={Oncology reports},
  year={2015},
  volume={34 4},
  pages={
          1845-52
        }
}
Radiotherapy resistance remains a major obstacle for patients with breast cancer. miRNAs are important regulators in many biological processes including proliferation, apoptosis, invasion and metastasis and response to treatment in different types of tumors. Here, we describe the role of miRNA-144 in the regulation of radiotherapy sensitivity, migration and invasion of breast cancer cells. The cell survival rate of breast cancer cells was measured by WST-1 assay after irradiation. The caspase-3… 
View on PubMed
spandidos-publications.com
49 Citations
Highly Influential Citations
1
Background Citations
25

Figures from this paper

49 Citations

Citation Type

Citation Type

MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55
TLDR
MiR-144 suppressed cell proliferation, migration, invasion and induced cell cycle arrest and cell apoptosis by repressing CEP55, which might provide a promising therapy for clinical treatment.
MiR-144 inhibits growth and metastasis in colon cancer by down-regulating SMAD4
TLDR
Findings about miR-144/SMAD4 pair provide a novel therapeutic method for colon cancer patients by repressing the SMAD4 expression both in mRNA and protein.
miR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1/2-mediated epithelial mesenchymal transition process
TLDR
It is demonstrated that miR-144 functions as a tumor suppressor in breast cancer at least partly through inhibiting ZEB1/2-mediated epithelial mesenchymal transition process.
miR-22 suppresses tumorigenesis and improves radiosensitivity of breast cancer cells by targeting Sirt1
TLDR
miR-22 suppresses tumorigenesis and improves radiosensitivity of breast cancer cells by targeting sirt1, providing a promising therapeutic target for breast cancer.
Targeting MicroRNAs in Prostate Cancer Radiotherapy
TLDR
Several important miRNAs in CaP radiation response are summarized and the regulation of the major signalling pathways and biological processes by miRN as well as potential predictive biomarkers and/or therapeutic targets to improve CaP radiosensitivity are discussed.
miR-144-3p inhibited the growth, metastasis and epithelial-mesenchymal transition of colorectal adenocarcinoma by targeting ZEB1/2
TLDR
It is reported that miR-144-3p expression level was significantly down-regulated in CRA tissues compared with matched noncancerous colorectal mucosae tissues and it is confirmed that ZEB1 and ZEB2 down-regulation collaboratively mediated the inhibitory effect of miR/2 on proliferation, invasion and EMT of CRA cells.
miR‐144 reverses cisplatin resistance in cervical cancer via targeting LHX2
Mounting evidence showed that microRNAs involve in development and chemoresistance of various human cancers. We explored the roles and mechanisms of miR‐144 in resistance to cisplatin (CDDP) of…
MicroRNA-144-3p suppresses gastric cancer progression by inhibiting epithelial-to-mesenchymal transition through targeting PBX3.
miR-144-3p Induces Cell Cycle Arrest and Apoptosis in Pancreatic Cancer Cells by Targeting Proline-Rich Protein 11 Expression via the Mitogen-Activated Protein Kinase Signaling Pathway.
TLDR
It is demonstrated that miR-144-3p was decreased in PC tissues and PANC-1 cells, whereas proline-rich protein 11 (PRR11) was remarkably increased, indicating that the targeting of miR+3p could serve as a potential therapeutic strategy for the treatment of PC.
MiR-144-3p inhibits cell proliferation and induces apoptosis in multiple myeloma by targeting c-Met.
TLDR
It is demonstrated that miR-144-3p functions as a tumor suppressor in MM by targeting c-MET, suggesting that miP-144 -3p might serve as a potential therapeutic target in MM.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 40 REFERENCES
MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN.
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
TLDR
It is shown that CBD inhibits human breast cancer cell proliferation and invasion through differential modulation of the extracellular signal-regulated kinase (ERK) and reactive oxygen species (ROS) pathways, and that both pathways lead to down-regulation of Id-1 expression.
MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN)
TLDR
Dysregulation of miR-20b plays critical roles in the breast cancer tumorigenesis, at least in part via targeting the tumor suppressor PTEN, and this microRNA may serve as a potential diagnostic marker and therapeutic target for breast cancer.
miR‐144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling
TLDR
It is found that the miR‐144 expression level is significantly decreased in bladder cancer cell lines as well as in clinical cancer tissues, and it is demonstrated that enhancer of zeste homolog 2 (EZH2) is a target gene of miR•144.
miRNA-95 mediates radioresistance in tumors by targeting the sphingolipid phosphatase SGPP1.
TLDR
Next-generation sequencing and combined in silico prediction and microarray expression analyses identify and validated the sphingolipid phosphatase SGPP1, an antagonist of sphingosine-1-phosphate signaling, as a target of miR-95 that promotes radiation resistance.
Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway.
TLDR
Investigation of the clinicopathologic magnitude of the mTOR pathway regulating microRNA, miR-144 in colorectal cancer (CRC) cases and the correlation between CRC prognosis and the expression of 16 genes in the Akt/mTOR pathway indicated that high expression of Rictor was associated with poor prognosis of CRC.
Role of MicroRNA in Response to Ionizing Radiations: Evidences and Potential Impact on Clinical Practice for Radiotherapy
TLDR
MiRNAs represent a great opportunity to enhance the efficacy of radiotherapy treatments—they can be used to profile the radioresistance of tumors before radiotherapy, monitor their response throughout the treatment, thus helping to select intensification strategies, and also to define the final response to therapy along with risks of recurrence or metastatization.
Transcriptional control of PAX4-regulated miR-144/451 modulates metastasis by suppressing ADAMs expression
TLDR
This discovery suggests that a PAX4–miR-144/451–ADAMs axis regulates human epithelial cancer metastasis, thus opening up therapeutic possibilities and predicting prognosis for those cancer types.
[PTEN: a new target in inhibiting of tumor invasion and metastasis].
TLDR
This article is reviewed about how PTEN participates in inhibiting tumor cell invasion and metastasis.
...
1
2
3
4
...